New York, NY (PRWEB) August 13, 2014
Whitehouse Laboratories is excited to announce that once again it will be participating in the Contract Pharma Magazine’s 13th Annual Contracting & Outsourcing Conference & Tabletop Exhibition, devoted to outsourcing in the pharma and biopharmaceutical industries. The event will be held on September 18-19, 2014 at the Hyatt Regency New Brunswick, NJ, located in the heart of New Jersey’s pharmaceutical industry. The tabletop exhibition will be held on Thursday, September 18th with an additional half day of sessions held on Friday, September 19th. The Conference will feature two Key Note Speakers representing the FDA. The first keynote will review the FDA’s current thinking on product specification while the second presentation will provide an up to date review of all the current trends in the inspection process from the FDA perspective. Those attending will learn firsthand the ten most critical inspection issues based upon FDA audits over the past year.
“This conference provides an excellent platform that brings together key industry companies and the service providers that work with them to bring quality products to the market. This gives us a great arena to touch base with current clients and meet potential new ones while learning all the latest industry trends,” states Whitehouse Labs COO Mark Stier.
In addition to the keynote FDA presentation, other key topics to be covered include the qualification of injectable products and package system and improving data integrity programs. The qualification of injectable package systems has seen exponential growth over the past few years and development of test programs in this area is critical to insure product success and patient safety. Whitehouse Labs team members will be available to discuss the development and validation work they have performed over the past three years that help clients meet their quality objectives with injectable syringe package systems. As this type of quality control testing requires high testing volumes, maintaining integral data systems is critical to insure success for the product at the patient level and to meet the strict regulatory requirements.
Also, conference attendees will have the chance to learn about recent USP method revisions and pending updates including the new 1207 chapter that will focus on container closure integrity testing as well as the controversial revisions to the USP 661 and USP 671 chapters. Conference attendees will also have the chance to register with Whitehouse Labs to receive monthly updates on USP changes directly from our quality review staff. All of the key service area directors for Whitehouse Laboratories will be available at the conference to discuss and review all presentation topics and to bring booth attendees up to date on new test methods, recent laboratory expansion plans and new services. For those taking the time to visit the booth, Whitehouse Labs will be handing out its most recent article series on Container Closure Integrity Testing, a valuable tool that helps explain most optimal methods for your package system. For additional information on attending the conference, please visit http://www.contractpharma.com.
Whitehouse Laboratories - The Testing Partner to Manufacturing Companies, Whitehouse Labs is an FDA regulated, DEA Licensed, ISO 17025 and ISTA certified contract service provider to the pharmaceutical, medical device, personal and consumer product industries. Whitehouse Laboratories offers analytical services for the testing of materials, finished products, container and package systems that enable our clients to meet and exceed the required quality standards established by the key regulatory agencies.